Bolger Timothy A, Zhao Xuan, Cohen Todd J, Tsai Chih-Cheng, Yao Tso-Pang
Department of Pharmacology and Cancer Biology, Duke University, Durham, North Carolina 27710, USA.
J Biol Chem. 2007 Oct 5;282(40):29186-92. doi: 10.1074/jbc.M704182200. Epub 2007 Jul 23.
Ataxin-1 is a neurodegenerative disorder protein whose mutant form causes spinocerebellar ataxia type-1 (SCA1). Evidence suggests that ataxin-1 may function as a transcription repressor. However, neither the importance of this putative transcriptional repression activity in neural cytotoxicity nor the transcriptional targets of ataxin-1 are known. Here we identify the MEF2-HDAC4 transcriptional complex involved in neuron survival as a target of ataxin-1. We show that ataxin-1 binds specifically to histone deacetylase-4 (HDAC4) and MEF2 and colocalizes with them in nuclear inclusion bodies. Significantly, these interactions are greatly reduced by the S776A mutation, which largely abrogates the cytotoxicity of ataxin-1. Supporting the importance of these interactions, we show that wild type ataxin-1 represses MEF2-dependent transcription, whereas the S776A mutant is less potent. Furthermore, overexpression of MEF2 can partially reverse cytotoxicity caused by ataxin-1. Our results identify the MEF2-HDAC4 complex as a target for ataxin-1 transcriptional repression activity and suggest a novel pathogenic mechanism whereby ataxin-1 sequesters and inhibits the neuronal survival factor MEF2.
ataxin-1是一种神经退行性疾病蛋白,其突变形式会导致1型脊髓小脑共济失调(SCA1)。有证据表明ataxin-1可能作为一种转录抑制因子发挥作用。然而,这种假定的转录抑制活性在神经细胞毒性中的重要性以及ataxin-1的转录靶点均不为人所知。在此,我们确定参与神经元存活的MEF2-HDAC4转录复合物是ataxin-1的一个靶点。我们发现ataxin-1能特异性地与组蛋白去乙酰化酶-4(HDAC4)和MEF2结合,并与它们在核内包涵体中共定位。重要的是,S776A突变能极大地减少这些相互作用,该突变在很大程度上消除了ataxin-1的细胞毒性。为支持这些相互作用的重要性,我们表明野生型ataxin-1会抑制MEF2依赖的转录,而S776A突变体的抑制作用较弱。此外,MEF2的过表达能部分逆转ataxin-1所导致的细胞毒性。我们的研究结果确定MEF2-HDAC4复合物是ataxin-1转录抑制活性的一个靶点,并提示了一种新的致病机制,即ataxin-1隔离并抑制神经元存活因子MEF2。